<VariationArchive VariationID="190171" VariationName="NM_000124.4(ERCC6):c.3952_3953del (p.Arg1318fs)" VariationType="Deletion" Accession="VCV000190171" Version="13" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-05-08" DateCreated="2015-05-09" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="187988" VariationID="190171">
      <GeneList>
        <Gene Symbol="ERCC6" FullName="ERCC excision repair 6, chromatin remodeling factor" GeneID="2074" HGNC_ID="HGNC:3438" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="49434881" stop="49539538" display_start="49434881" display_stop="49539538" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="50664490" stop="50747146" display_start="50664490" display_stop="50747146" Strand="-" />
          </Location>
          <OMIM>609413</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000124.4(ERCC6):c.3952_3953del (p.Arg1318fs)</Name>
      <CanonicalSPDI>NC_000010.11:49461381:CT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="49461382" stop="49461383" display_start="49461382" display_stop="49461383" variantLength="2" positionVCF="49461381" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="50669428" stop="50669429" display_start="50669428" display_stop="50669429" variantLength="2" positionVCF="50669427" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>R1318fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.50669428_50669429del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.50669428_50669429del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000124.3" sequenceAccession="NM_000124" sequenceVersion="3" change="c.3952_3953del">
            <Expression>NM_000124.3:c.3952_3953del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.49461382_49461383del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.49461382_49461383del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009442.1" sequenceAccession="NG_009442" sequenceVersion="1" change="g.82719_82720del">
            <Expression>NG_009442.1:g.82719_82720del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000124.4" sequenceAccession="NM_000124" sequenceVersion="4" change="c.3952_3953del" MANESelect="true">
            <Expression>NM_000124.4:c.3952_3953del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000115.1" sequenceAccession="NP_000115" sequenceVersion="1" change="p.Arg1318fs">
            <Expression>NP_000115.1:p.Arg1318fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001346440.2" sequenceAccession="NM_001346440" sequenceVersion="2" change="c.3952_3953del">
            <Expression>NM_001346440.2:c.3952_3953del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001333369.1" sequenceAccession="NP_001333369" sequenceVersion="1" change="p.Arg1318fs">
            <Expression>NP_001333369.1:p.Arg1318fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_465" sequenceAccession="LRG_465">
            <Expression>LRG_465:g.82719_82720del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_465t1" sequenceAccession="LRG_465t1">
            <Expression>LRG_465t1:c.3952_3953del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000124.4" sequenceAccession="NM_000124" sequenceVersion="4" change="c.3952_3953delAG" MANESelect="true">
            <Expression>NM_000124.4:c.3952_3953delAG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000124.2" sequenceAccession="NM_000124" sequenceVersion="2" change="c.3952_3953delAG">
            <Expression>NM_000124.2:c.3952_3953delAG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA274713" DB="ClinGen" />
        <XRef Type="rs" ID="765825423" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000124.4(ERCC6):c.3952_3953del (p.Arg1318fs) AND Cockayne syndrome type 2" Accession="RCV000170390" Version="1">
        <ClassifiedConditionList TraitSetID="433">
          <ClassifiedCondition DB="MedGen" ID="C0751038">Cockayne syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2013-10-22" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000124.4(ERCC6):c.3952_3953del (p.Arg1318fs) AND multiple conditions" Accession="RCV000666483" Version="3">
        <ClassifiedConditionList TraitSetID="43959">
          <ClassifiedCondition DB="MedGen" ID="C0220722">Cerebrooculofacioskeletal syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0751038">Cockayne syndrome type 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0265201">DE SANCTIS-CACCHIONE SYNDROME</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2017-04-10" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000124.4(ERCC6):c.3952_3953del (p.Arg1318fs) AND not provided" Accession="RCV001231998" Version="10">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-29" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000124.4(ERCC6):c.3952_3953del (p.Arg1318fs) AND Cockayne syndrome" Accession="RCV002271445" Version="1">
        <ClassifiedConditionList TraitSetID="13315">
          <ClassifiedCondition DB="MedGen" ID="C0009207">Cockayne syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-29" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2015-05-09" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18628313</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29572252</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31130284</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32453336</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32496904</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32504035</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32853555</ID>
        </Citation>
        <DescriptionHistory Dated="2020-07-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13315" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6530" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cockayne syndrome</ElementValue>
                <XRef ID="MONDO:0016006" DB="MONDO" />
                <XRef ID="21086008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dwarfism-retinal atrophy-deafness syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Progeria-like syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Progeroid nanism</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes: CS type I, the "classic" or "moderate" form; CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome; CS type III, a milder and later-onset form; COFS syndrome, a fetal form of CS. CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years. CS type III is a phenotype in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I. COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).</Attribute>
                <XRef ID="NBK1342" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6122" />
                <XRef ID="6122" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301516</ID>
                <ID Source="BookShelf">NBK1342</ID>
              </Citation>
              <XRef ID="191" DB="Orphanet" />
              <XRef ID="C0009207" DB="MedGen" />
              <XRef ID="MONDO:0016006" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="43959" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1348" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cerebrooculofacioskeletal syndrome 1</ElementValue>
                <XRef ID="MONDO:0008955" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebro-oculo-facio-skeletal syndrome 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">COFS1</ElementValue>
                <XRef Type="MIM" ID="214150" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15150" />
                <XRef ID="15150" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C0220722" DB="MedGen" />
              <XRef ID="MONDO:0008955" DB="MONDO" />
              <XRef Type="MIM" ID="214150" DB="OMIM" />
            </Trait>
            <Trait ID="1524" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cockayne syndrome type 2</ElementValue>
                <XRef ID="MONDO:0019570" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne Syndrome, Type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome  type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CSB</ElementValue>
                <XRef Type="MIM" ID="133540" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1420" />
                <XRef ID="1420" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes: CS type I, the "classic" or "moderate" form; CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome; CS type III, a milder and later-onset form; COFS syndrome, a fetal form of CS. CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years. CS type III is a phenotype in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I. COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).</Attribute>
                <XRef ID="NBK1342" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301516</ID>
                <ID Source="BookShelf">NBK1342</ID>
              </Citation>
              <XRef ID="191" DB="Orphanet" />
              <XRef ID="90322" DB="Orphanet" />
              <XRef ID="C0751038" DB="MedGen" />
              <XRef ID="MONDO:0019570" DB="MONDO" />
              <XRef Type="MIM" ID="133540" DB="OMIM" />
            </Trait>
            <Trait ID="930" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Xerodermic idiocy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">DE SANCTIS-CACCHIONE SYNDROME</ElementValue>
                <XRef ID="De+Sanctis-Cacchione+Syndrome/2123" DB="Genetic Alliance" />
                <XRef Type="MIM" ID="278800" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609413.0002" DB="OMIM" />
                <XRef ID="414673004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ERCC6</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8276" />
                <XRef ID="8276" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1569" DB="Orphanet" />
              <XRef ID="C0265201" DB="MedGen" />
              <XRef ID="MONDO:0010217" DB="MONDO" />
              <XRef Type="MIM" ID="278800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="433" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1524" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cockayne syndrome type 2</ElementValue>
                <XRef ID="MONDO:0019570" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne Syndrome, Type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome  type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CSB</ElementValue>
                <XRef Type="MIM" ID="133540" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1420" />
                <XRef ID="1420" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes: CS type I, the "classic" or "moderate" form; CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome; CS type III, a milder and later-onset form; COFS syndrome, a fetal form of CS. CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years. CS type III is a phenotype in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I. COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).</Attribute>
                <XRef ID="NBK1342" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301516</ID>
                <ID Source="BookShelf">NBK1342</ID>
              </Citation>
              <XRef ID="191" DB="Orphanet" />
              <XRef ID="90322" DB="Orphanet" />
              <XRef ID="C0751038" DB="MedGen" />
              <XRef ID="MONDO:0019570" DB="MONDO" />
              <XRef Type="MIM" ID="133540" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="405046" SubmissionDate="2015-04-13" DateLastUpdated="2015-05-09" DateCreated="2015-05-09">
        <ClinVarSubmissionID localKey="NM_000124.3:c.3952_3953delAG|OMIM:133540" />
        <ClinVarAccession Accession="SCV000222810" DateUpdated="2015-05-09" DateCreated="2015-05-09" Type="SCV" Version="1" SubmitterName="Claritas Genomics" OrgID="1179" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-10-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2007</Attribute>
          <Citation>
            <ID Source="PubMed">18414213</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000124.3:c.3952_3953delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cockayne syndrome, type B</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="133540" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1541091" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="458822|OMIM:133540;214150;278800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000790787" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="C" referenceAllele="CCT" start="50669427" stop="50669429" variantLength="3" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000124.2:c.3952_3953delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="133540" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="214150" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="278800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2477435" SubmissionDate="2020-02-26" DateLastUpdated="2020-05-31" DateCreated="2020-05-31">
        <ClinVarSubmissionID localKey="CA274713|MedGen:C0265201,C0751038,C0220722" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001251489" DateUpdated="2020-05-31" DateCreated="2020-05-31" Type="SCV" Version="1" SubmitterName="UNC Molecular Genetics  Laboratory, University of North Carolina at Chapel Hill" OrgID="506663" OrganizationCategory="laboratory" OrgAbbreviation="UNC MGL" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.3952_3953delAG (p.R1318Gfs) variant is a frameshift deletion of two nucleotides predicted to result in a nonfunctional ERCC6 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>exome sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000124.4:c.3952_3953delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DE SANCTIS-CACCHIONE SYNDROME</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0265201" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cockayne syndrome B</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0751038" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cerebrooculofacioskeletal syndrome 1</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0220722" Type="CUI" />
          </Trait>
        </TraitSet>
        <StudyName>NSIGHT-NC NEXUS</StudyName>
        <StudyDescription>The North Carolina Newborn Exome Sequencing for Universal Screening (NC NEXUS) study explored the possible use of genomic sequencing in the context of newborn screening and studied the responses of parents to this new technology.</StudyDescription>
        <Comment>carrier finding</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB7037417</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5001379" SubmissionDate="2022-07-29" DateLastUpdated="2022-08-03" DateCreated="2022-08-03">
        <ClinVarSubmissionID localKey="NM_000124.3:c.3952_3953delAG|MedGen:C0009207" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002556093" DateUpdated="2022-08-03" DateCreated="2022-08-03" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31130284</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29572252</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32496904</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32504035</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32853555</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32453336</ID>
          </Citation>
          <Comment>Variant summary: ERCC6 c.3952_3953delAG (p.Arg1318GlyfsX12) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic in ClinVar database. The variant allele was found at a frequency of 2e-05 in 251212 control chromosomes (gnomAD). c.3952_3953delAG has been reported in the literature in two individuals affected with Cockayne Syndrome (Calmels_2018), one individual with clinical diagnosis and family history of hearing loss, loss of ambulation, hypotonia, cerebellar ataxia and sensory neuropathy (Monies_2019), one individual affected with acute lymphoblastic leukemia (Qin_2020) and one individual affected with malignant peritoneal mesothelioma (Hung_2020). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic (n=2) and likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000124.3:c.3952_3953delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0009207" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11876943</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3877813" SubmissionDate="2023-02-01" DateLastUpdated="2023-11-11" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="GDXSV:258161" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001983862" DateUpdated="2023-11-11" DateCreated="2021-10-30" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Reported in two unrelated patients with Cockayne syndrome who each harbored another variant in the ERCC6 gene in published literature (Calmels et al., 2018); Identified in a patient with a clinical diagnosis and family history of hearing loss, loss of ambulation, hypotonia, cerebellar ataxia and sensory neuropathy who underwent exome sequencing (Monies et al., 2019); this individual also harbored an intronic variant in ERCC6 though its clinical significance was considered to be unknown; Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31130284, 29572252, 18628313, 9443879)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2711372</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000124.2:c.3952_3953del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_162_20230201054205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_63_20211027054205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_79_20220105054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2739553" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="5885443|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001404539" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18628313</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29572252</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29572252</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg1318Glyfs*12) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). This variant is present in population databases (rs765825423, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with Cockayne syndrome type B (PMID: 29572252). ClinVar contains an entry for this variant (Variation ID: 190171). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.50669428_50669429del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2477435" TraitType="Disease" MappingType="Name" MappingValue="Cerebrooculofacioskeletal syndrome 1" MappingRef="Preferred">
        <MedGen CUI="C0220722" Name="Cerebrooculofacioskeletal syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2739553" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1541091" TraitType="Disease" MappingType="XRef" MappingValue="133540" MappingRef="OMIM">
        <MedGen CUI="C0751038" Name="Cockayne syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2477435" TraitType="Disease" MappingType="Name" MappingValue="Cockayne syndrome B" MappingRef="Preferred">
        <MedGen CUI="C0751038" Name="Cockayne syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5001379" TraitType="Disease" MappingType="XRef" MappingValue="C0009207" MappingRef="MedGen">
        <MedGen CUI="C0009207" Name="Cockayne syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1541091" TraitType="Disease" MappingType="XRef" MappingValue="278800" MappingRef="OMIM">
        <MedGen CUI="C0265201" Name="DE SANCTIS-CACCHIONE SYNDROME" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3877813" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2477435" TraitType="Disease" MappingType="Name" MappingValue="DE SANCTIS-CACCHIONE SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0265201" Name="DE SANCTIS-CACCHIONE SYNDROME" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1541091" TraitType="Disease" MappingType="XRef" MappingValue="214150" MappingRef="OMIM">
        <MedGen CUI="C0220722" Name="Cerebrooculofacioskeletal syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="405046" TraitType="Disease" MappingType="Name" MappingValue="Cockayne syndrome, type B" MappingRef="Preferred">
        <MedGen CUI="C0751038" Name="Cockayne syndrome type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

